Frontotemporal Lobar Degeneration  >>  EVP-0334  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EVP-0334 / Forum Pharmaceuticals
NCT02149160 / 2014-001489-85: Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

Unknown status
2a
30
Europe, US
FRM-0334, Placebo
FORUM Pharmaceuticals Inc
Granulin Mutation
08/16
 

Download Options